This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignee: Soin Therapeutics LLC. Active years: 2025-2026.
Company Filing History:
1 out of 2 Years Active: 2025-2026
Title: Robert P Giannini, Jr: Innovator in Chronic Pain Treatment
Introduction
Robert P Giannini, Jr. is a notable inventor based in Riverside, CA (US). He has made significant contributions to the field of medicine, particularly in the treatment of chronic pain. His innovative approach has garnered attention in the medical community.
Latest Patents
Giannini holds a patent for "Methods of using low dose naltrexone to treat chronic pain." This patent outlines methods that involve administering a first amount of naltrexone in an immediate-release agent and a second amount in a modified-release agent. His work aims to provide effective relief for patients suffering from chronic pain.
Career Highlights
Giannini's career is marked by his dedication to improving patient outcomes through innovative treatments. His patent reflects his commitment to exploring new methodologies in pain management. He is associated with Soin Therapeutics LLC, where he continues to develop and refine his ideas.
Collaborations
Giannini collaborates with talented professionals in his field, including Amol Soin and Shweta U Sinkar. Their combined expertise enhances the potential for groundbreaking advancements in chronic pain treatment.
Conclusion
Robert P Giannini, Jr. is a pioneering inventor whose work in low dose naltrexone offers hope for those suffering from chronic pain. His contributions to the field are invaluable and demonstrate the impact of innovative thinking in medicine.